| Literature DB >> 18513445 |
Randa Salah1, Najla Dar-Odeh, Osama Abu Hammad, Asem A Shehabi.
Abstract
BACKGROUND: This study investigated the prevalence of Enterococcus faecalis, its putative virulence factors and antimicrobial susceptibility in individuals with and without dental diseases. A total of 159 oral rinse specimens were collected from patients (n = 109) suffering from dental diseases and healthy controls (n = 50).Entities:
Year: 2008 PMID: 18513445 PMCID: PMC2424041 DOI: 10.1186/1472-6831-8-17
Source DB: PubMed Journal: BMC Oral Health ISSN: 1472-6831 Impact factor: 2.757
Detection of Enterococcus species in patients and controls
| Characteristics | 109 Patients with dental diseases No. (%) | 50 Controls persons No. (%) |
| Age mean (years) | 36.4 ± 13.98 | 28.3 ± 12.59 |
| Male | 39 (36) | 24 (48) |
| Female | 70 (64) | 26 (52) |
| 8 (7.3) | 0 | |
| 2 (1.8) | 0 |
Distribution of 8 E. faecalis isolates in association of sex, smoking, oral hygiene and dental diseases among 109 patients
| Characteristics | Positive | Negative | Total No. | P-value*** |
| Female | 7 | 63 | 70 | 0.134 |
| Male | 1 | 38 | 39 | |
| Nonsmoker | 7 | 83 | 90 | 0.228 |
| Smoker | 1 | 18 | 19 | |
| Poor Oral hygiene | 7 | 68 | 75 | 0.222 |
| Good Oral hygiene | 1 | 33 | 34 | |
| Gingivitis +ve | 7 | 64 | 71 | 0.161 |
| Gingivitis -ve | 1 | 37 | 38 | |
| necrotic pulps | 8** | 101 | 109 | 0 |
| caries +ve | 4** | 77 | 81 | 0.115 |
| Caries -ve | 4 | 24 | 28 |
*colony count: 2 – 50 × 103colonies/ml.
** Each one patient was treated with antibiotics during the last month.
*** Not significant between positive E. faecalis and each of sex, smoking, oral hygiene, gingivitis, caries but significant with necrotic puples.
Presence of 16S rRNA gene and prevalence of esp, cylA, ace, efaA genes among the 8 oral E. faecalis isolates detected by PCR.
| Isolate No. | 16S rRNA | ||||
| 3 | + | - | - | + | + |
| 44 | + | - | - | + | + |
| 1 | + | - | - | + | + |
| 2 | + | - | + | + | + |
| 6 | + | - | - | + | + |
| 12 | + | - | - | + | + |
| 18 | + | - | - | + | + |
| 59 | + | - | + | + | + |
| Total strains No. (%) | 8 (100%) | 0 (0.0%) | 2 (25%) | 8 (100%) | 8 (100%) |
*Two isolates expressed hemolytic activity in vitro
Figure 1Distribution of M, 100 bp DNA marker; Lane 1, efaA (688 bp); positive control (E. faecalis ATCC 29212); Lane 2, efaA negative control; Lanes 3 to 10, positive to efaA among oral E. faecalis isolates.
Antimicrobial susceptibility of 8 E. faecalis by disc diffusion method
| Antimicrobial agents | No. (%) of isolates susceptible |
| Ampicillin | 8 (100) |
| Chloramphenicol | 8 (100) |
| Ciprofloxacin | 8 (100) |
| Teicoplanin | 8 (100) |
| Vancomycin | 8 (100) |
| Erythromycin | 5 (62.5)* |
| Gentamycin | Null |
| Clindamycin | Null |
| Oxacillin | Null |
Harbored only ace, efaA genes.
E. faecalis primers used in the study
| Ef16SF 5' – CCGAGTGCTTGCACTCAATTGG – 3' | 138 | 17 | |
| Ef16SR 5' – CTCTTATGCCATGCGGCATAAAC – 3' | |||
| Esp | 5'-TTGCTAATGCTAGTCCACGACC-3' | 932 | 18 |
| 5'-GCGTCAACACTTGCATTGCCGA-3' | |||
| cylA | 5'-GACTCGGGGATTGATAGGC-3' | 688 | 15 |
| 5'-GCTGCTAAAGCTGCGCTTAC-3' | |||
| ace | 5'-GGAATGACCGAGAACGATGGC-3' | 616 | 15 |
| 5'-GCTTGATGTTGGCCTGCTTCCG-3' | |||
| efaA | 5'-GCCAATTGGGACAGACCCTC-3' | 688 | 15 |
| 5'-CGCCTTCTGTTCCTTCTTTGGC-3' |